Company Overview

TONIX PHARMACEUTICALS HOLDING CORP.

TNXP
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
13M
2025 FY
Net Income
-124M
2025 FY
Shares Outstanding
9M
2025 FY
EPS
-14.57USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1430306
Exchange
Nasdaq
Location
US